BioCentury
ARTICLE | Preclinical News

Amgen team describes GDF15's role in obesity

October 18, 2017 7:21 PM UTC

In a paper published Wednesday in Science Translational Medicine, researchers from Amgen Inc. (NASDAQ:AMGN) showed the involvement of growth differentiation factor 15 (GDF15) in regulating body weight in mice, rats, and non-human primates.

Amgen is the fifth company in the past three months to publish results of a study concerning GDF15 and obesity. In August, Novo Nordisk A/S (CSE:NOVOB; NYSE:NVO), Eli Lilly and Co. (NYSE:LLY) and the Janssen Research & Development LLC unit of Johnson & Johnson (NYSE:JNJ) published related papers in Nature Medicine, while NGM Biopharmaceuticals Inc. (South San Francisco, Calif.) published a paper in Nature in September (see BioCentury Innovations, Sept. 21 and BioCentury Extra, Aug. 28 & Oct. 2)...